Patient Experiences and Preferences Regarding Medication Cost Discussions Among Heart Failure Patients in Singapore: A Qualitative Survey

Qianyu Shen,1 Dennis Chin Wee Chua,2 Po Fun Chan,3 Sean Wei Jun Chan,1 Hwee-Lin Wee1 1Saw Swee Hock School of Public Health, National University of Singapore, Singapore, Singapore; 2Department of Pharmacy, Ng Teng Fong General Hospital, Singapore, Singapore; 3Department of Cardiology, Ng Teng Fong G...

Full description

Saved in:
Bibliographic Details
Main Authors: Shen Q, Chua DCW, Chan PF, Chan SWJ, Wee HL
Format: Article
Language:English
Published: Dove Medical Press 2025-02-01
Series:Patient Preference and Adherence
Subjects:
Online Access:https://www.dovepress.com/patient-experiences-and-preferences-regarding-medication-cost-discussi-peer-reviewed-fulltext-article-PPA
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849724270926626816
author Shen Q
Chua DCW
Chan PF
Chan SWJ
Wee HL
author_facet Shen Q
Chua DCW
Chan PF
Chan SWJ
Wee HL
author_sort Shen Q
collection DOAJ
description Qianyu Shen,1 Dennis Chin Wee Chua,2 Po Fun Chan,3 Sean Wei Jun Chan,1 Hwee-Lin Wee1 1Saw Swee Hock School of Public Health, National University of Singapore, Singapore, Singapore; 2Department of Pharmacy, Ng Teng Fong General Hospital, Singapore, Singapore; 3Department of Cardiology, Ng Teng Fong General Hospital, Singapore, SingaporeCorrespondence: Qianyu Shen, Saw Swee Hock School of Public Health, National University of Singapore, 12 Science Drive 2, Singapore 117549, Singapore, Email shenqianyu1992@gmail.comPurpose: Cost of novel medications has increased worldwide, causing financial toxicity to heart failure patients. Patients can discuss medication costs with clinicians to manage financial burden, but such discussion can be uncommon. This study seeked to investigate the experiences and preferences of heart failure patients in Singapore regarding medication cost discussions to develop effective strategies to encourage such conversations.Patients and Methods: Participants were recruited from a hospital outpatient heart failure clinic in 2022 to participate in a qualitative survey containing open-ended questions. Inclusion criteria were patients aged 21 years and above, diagnosed with heart failure, and capable of comprehending English. There were no exclusion criteria. Conventional content analysis was performed on collected responses.Results: Among forty-eight heart failure patients (median age: 63.5 years, 43.8% male, 72.9% Chinese) who participated, most (93.8%) wanted to discuss medication costs with clinicians for reasons such as concern over affordability, taking ownership of health, making informed decisions, minimizing inconvenience, and obtaining tailored cost information. Affordability of medications was a concern for patients but only 8.3% of patients actually had regular cost discussions with clinicians in the past year. Patients mentioned a lack of initiative from the clinicians, limited cost awareness, and time constraints as reasons why cost conversations did not happen.Conclusion: Outpatient heart failure patients in Singapore desire to discuss medication costs with clinicians but few participants reported having such conversations. Barriers hindering cost discussions have to be addressed to ensure patients make an informed medication decision with minimal financial burden.Keywords: cost discussion, decision making, patient experience, patient preference, heart failure
format Article
id doaj-art-09ffc709df0c4a87b1003fbe23c7559e
institution DOAJ
issn 1177-889X
language English
publishDate 2025-02-01
publisher Dove Medical Press
record_format Article
series Patient Preference and Adherence
spelling doaj-art-09ffc709df0c4a87b1003fbe23c7559e2025-08-20T03:10:47ZengDove Medical PressPatient Preference and Adherence1177-889X2025-02-01Volume 19407418100465Patient Experiences and Preferences Regarding Medication Cost Discussions Among Heart Failure Patients in Singapore: A Qualitative SurveyShen QChua DCWChan PFChan SWJWee HLQianyu Shen,1 Dennis Chin Wee Chua,2 Po Fun Chan,3 Sean Wei Jun Chan,1 Hwee-Lin Wee1 1Saw Swee Hock School of Public Health, National University of Singapore, Singapore, Singapore; 2Department of Pharmacy, Ng Teng Fong General Hospital, Singapore, Singapore; 3Department of Cardiology, Ng Teng Fong General Hospital, Singapore, SingaporeCorrespondence: Qianyu Shen, Saw Swee Hock School of Public Health, National University of Singapore, 12 Science Drive 2, Singapore 117549, Singapore, Email shenqianyu1992@gmail.comPurpose: Cost of novel medications has increased worldwide, causing financial toxicity to heart failure patients. Patients can discuss medication costs with clinicians to manage financial burden, but such discussion can be uncommon. This study seeked to investigate the experiences and preferences of heart failure patients in Singapore regarding medication cost discussions to develop effective strategies to encourage such conversations.Patients and Methods: Participants were recruited from a hospital outpatient heart failure clinic in 2022 to participate in a qualitative survey containing open-ended questions. Inclusion criteria were patients aged 21 years and above, diagnosed with heart failure, and capable of comprehending English. There were no exclusion criteria. Conventional content analysis was performed on collected responses.Results: Among forty-eight heart failure patients (median age: 63.5 years, 43.8% male, 72.9% Chinese) who participated, most (93.8%) wanted to discuss medication costs with clinicians for reasons such as concern over affordability, taking ownership of health, making informed decisions, minimizing inconvenience, and obtaining tailored cost information. Affordability of medications was a concern for patients but only 8.3% of patients actually had regular cost discussions with clinicians in the past year. Patients mentioned a lack of initiative from the clinicians, limited cost awareness, and time constraints as reasons why cost conversations did not happen.Conclusion: Outpatient heart failure patients in Singapore desire to discuss medication costs with clinicians but few participants reported having such conversations. Barriers hindering cost discussions have to be addressed to ensure patients make an informed medication decision with minimal financial burden.Keywords: cost discussion, decision making, patient experience, patient preference, heart failurehttps://www.dovepress.com/patient-experiences-and-preferences-regarding-medication-cost-discussi-peer-reviewed-fulltext-article-PPAcost discussiondecision makingpatient experiencepatient preferenceheart failure
spellingShingle Shen Q
Chua DCW
Chan PF
Chan SWJ
Wee HL
Patient Experiences and Preferences Regarding Medication Cost Discussions Among Heart Failure Patients in Singapore: A Qualitative Survey
Patient Preference and Adherence
cost discussion
decision making
patient experience
patient preference
heart failure
title Patient Experiences and Preferences Regarding Medication Cost Discussions Among Heart Failure Patients in Singapore: A Qualitative Survey
title_full Patient Experiences and Preferences Regarding Medication Cost Discussions Among Heart Failure Patients in Singapore: A Qualitative Survey
title_fullStr Patient Experiences and Preferences Regarding Medication Cost Discussions Among Heart Failure Patients in Singapore: A Qualitative Survey
title_full_unstemmed Patient Experiences and Preferences Regarding Medication Cost Discussions Among Heart Failure Patients in Singapore: A Qualitative Survey
title_short Patient Experiences and Preferences Regarding Medication Cost Discussions Among Heart Failure Patients in Singapore: A Qualitative Survey
title_sort patient experiences and preferences regarding medication cost discussions among heart failure patients in singapore a qualitative survey
topic cost discussion
decision making
patient experience
patient preference
heart failure
url https://www.dovepress.com/patient-experiences-and-preferences-regarding-medication-cost-discussi-peer-reviewed-fulltext-article-PPA
work_keys_str_mv AT shenq patientexperiencesandpreferencesregardingmedicationcostdiscussionsamongheartfailurepatientsinsingaporeaqualitativesurvey
AT chuadcw patientexperiencesandpreferencesregardingmedicationcostdiscussionsamongheartfailurepatientsinsingaporeaqualitativesurvey
AT chanpf patientexperiencesandpreferencesregardingmedicationcostdiscussionsamongheartfailurepatientsinsingaporeaqualitativesurvey
AT chanswj patientexperiencesandpreferencesregardingmedicationcostdiscussionsamongheartfailurepatientsinsingaporeaqualitativesurvey
AT weehl patientexperiencesandpreferencesregardingmedicationcostdiscussionsamongheartfailurepatientsinsingaporeaqualitativesurvey